Advanced Enzyme Technologies share news, announcements and annual reports

NSE: ADVENZYMESBSE: 540025Pharmaceuticals & BiotechnologySmall Cap

Advanced Enzyme Technologies Limited · Face value ₹2 · Listed Aug 2016 · Issue price ₹896

₹281.45₹17.90 (6.79%)BSE ₹281.80

Share price at the NSE close on 2 Nov 2026. Previous close ₹263.55.

2 Nov: open ₹271.00, high ₹288.00, low ₹265.65

52-week range of traded prices to 2 Nov 2026

₹246.80Low, 26 Oct 2026₹419.00High, 11 May 2026

Market cap: ₹3,084 Cr912th largest listed
P/E: 18.05
P/B: 1.85
Dividend yield: 0.48%
ROE: 10.9%
ROCE: 11.2%
Debt to equity: 0.01
Volume, NSE: 9,44,23328.1% delivered

Advanced Enzyme Technologies board meetings

93 filed, newest first. Page 1 of 2.

Oct 2026
- 31 Oct · Board meeting
  Board of Directors at their meeting held today i.e. October 31, 2026 have analyzed the requests received from the promoter group members for their reclassification from promoter group category to public category shareholders, pursuant to Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended
- 23 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2026
Aug 2026
- 8 Aug · Board meeting
  Outcome of Board Meeting held on August 08, 2026.
- 1 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2026
May 2026
- 9 May · Board meeting
  Board has decided to defer the declaration of an interim dividend. While the Company continues to maintain a healthy financial position and robust liquidity, the Board intends to preserve capital as of now to provide necessary flexibility to the Company to evaluate other potential strategic avenues / corporate actions which can maximize long-term shareholder value. The Board may evaluate this at an appropriate time and the decision, if any, thereon shall be intimated by the Company to the Stock Exchange(s).
- 2 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026 and dividend
Jan 2026
- 23 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025
Nov 2025
- 4 Nov · Board meeting
  This is to inform that the Meeting of Board of Directors of the Company is scheduled to be held on Wednesday, November 12, 2025, inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025
Aug 2025
- 2 Aug · Board meeting
  Approval granted for investment of Rupees 10 million in the Equity Shares of Advanced Nutrazyme Private Limited, an existing Wholly Owned Subsidiary.
Jul 2025
- 25 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2025
May 2025
- 6 May · Board meeting
  Intimation of Board Meeting, Record date for interim dividend, if declared by the Board andclosure of Trading Window
Feb 2025
- 8 Feb · Board meeting
  Board meeting held on February 08, 2025.
- 1 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2024
Nov 2024
- 9 Nov · Board meeting
  Board meeting held on November 09, 2024.
Oct 2024
- 30 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024
Aug 2024
- 10 Aug · Board meeting
  Outcome of Board Meeting held on August 10, 2024.
- 2 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024
May 2024
- 11 May · Board meeting
  Outcome of Board Meeting held on May 11, 2024.
- 4 May · Board meeting
  This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 11, 2024, inter alia, to consider the following:To consider & approve annual Financial Statements (Standalone & Consolidated) of the Company for the financial year ended March 31, 2024 along with results of the fourth quarter;To consider & recommend Final dividend, if any, for the financial year ended March 31, 2024, and/or to consider & declare Interim Dividend, if any for the financial year ended March 31, 2025.The Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY2024-25, if any declared by the Board of Directors of the Company shall be Saturday, May 18, 2024.Closure of Trading Window:Further to our letter dated March 29, 2024 intimating closure of Trading Window, we wish to inform you that the Trading Window for dealing in the Securities of the Company will continue to remain closed up to May 13, 2024.
Feb 2024
- 10 Feb · Board meeting
  Outcome of Board Meeting held on February 10, 2024.
- 3 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023.
Nov 2023
- 7 Nov · Board meeting
  Outcome of Board Meeting held on November 07, 2023.
Oct 2023
- 31 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2023
Aug 2023
- 4 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2023
May 2023
- 13 May · Board meeting
  Outcome of Board Meeting held on May 13, 2023.
- 6 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2023 and dividend
Feb 2023
- 11 Feb · Board meeting
  With reference to the notice of Board Meeting dated February 04, 2023, we hereby inform that the Board of Directors of the Company at its meeting held on February 11, 2023 (commenced at 11.25 a.m. and concluded at 12.10 p.m.) has inter alia, transacted the following business: Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2022.Approved the allotment of 2,000 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.
- 4 Feb · Board meeting
  This is to inform that the Meeting of Board of Directors of Company is scheduled to be held through video conference on Saturday, February 11, 2023, inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2022.
Nov 2022
- 11 Nov · Board meeting
  With reference to the Board meeting notice dated November 04, 2022, we hereby inform that the Board of Directors in its meeting held on November 11, 2022 (commenced at 11:15 a.m. and concluded at 12:15 p.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2022.In view of the aforesaid, we hereby enclose the following:Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2022 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.This is for your information and for public at large.
- 4 Nov · Board meeting
  Board Meeting to be held on 11-Nov-2022 to consider financial statements for the period ended September 2022
Aug 2022
- 6 Aug · Board meeting
  With reference to the Board meeting notice dated July 30, 2022, we hereby inform that the Board of Directors in its meeting held on August 06, 2022 (commenced at 10:00 a.m. and concluded at 10:45 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30, 2022.In view of the aforesaid, we hereby enclose the following:Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2022 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.This is for your information and for public at large.
Jul 2022
- 30 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 06-08-2022, inter alia, to consider and approve un-audited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30 2022
May 2022
- 20 May · Board meeting
  Board Meeting held on 20-May-2022 to consider financial statements for the period ended March 2022 and Dividend
- 12 May · Board meeting
  Board Meeting to be held on 20-May-2022 to consider financial statements for the period ended March 31, 2022 and to consider, approve and recommend Final dividend, if any, for the financial year ended March 31, 2022
Feb 2022
- 5 Feb · Board meeting
  Outcome of Board Meeting held on February 05, 2022.
Jan 2022
- 28 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 05/02/2022, inter alia, to consider and approve un-audited financial results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2021
Nov 2021
- 2 Nov · Board meeting
  Board meeting held on November 02, 2021.
Oct 2021
- 26 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021
Aug 2021
- 7 Aug · Board meeting
  Board meeting held on August 07, 2021.
Jul 2021
- 31 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021
May 2021
- 30 May · Board meeting
  Outcome of Board Meeting held on May 29, 2021.
- 22 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2021 and dividend
Feb 2021
- 12 Feb · Board meeting
  Outcome of Board Meeting held on February 12, 2021.With reference to the Board meeting notice dated February 02, 2021, we hereby inform that the Board of Directors in its meeting held on February 12, 2021 (commenced at 10.45 a.m. and concluded at 11.35 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021.In view of the aforesaid, we hereby enclose the following: Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine year ended December 31, 2021 along with the Limited Review Report issued by B S R & Co. LLP, Statutory Auditors of the Company. Press Release and Earnings Presentation for the quarter and nine months ended December 31, 2020. Allotted 4500 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.This is for your information and for public at large.
- 2 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020
Nov 2020
- 12 Nov · Board meeting
  Outcome of Board Meeting held on November 12, 2020.
- 2 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2020
Aug 2020
- 12 Aug · Board meeting
  Outcome of Board Meeting held on August 12, 2020. We hereby inform that the Board of Directors in its meeting held on August 12, 2020 has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30, 2020. In view of the aforesaid, we hereby enclose the following: Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2020 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company as Annexure. Earnings Presentation for the quarter ended June 30, 2020.
- 4 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2020
May 2020
- 30 May · Board meeting
  Board meeting held on May 30, 2020.
- 23 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020 and dividend

Advanced Enzyme Technologies board meetings

Oct 2026

Aug 2026

May 2026

Jan 2026

Nov 2025

Aug 2025

Jul 2025

May 2025

Feb 2025

Nov 2024

Oct 2024

Aug 2024

May 2024

Feb 2024

Nov 2023

Oct 2023

Aug 2023

May 2023

Feb 2023

Nov 2022

Aug 2022

Jul 2022

May 2022

Feb 2022

Jan 2022

Nov 2021

Oct 2021

Aug 2021

Jul 2021

May 2021

Feb 2021

Nov 2020

Aug 2020

May 2020